One Wealth Capital Management LLC Makes New $584,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

One Wealth Capital Management LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,155 shares of the healthcare conglomerate’s stock, valued at approximately $584,000.

Other institutional investors have also recently made changes to their positions in the company. Diversified Trust Co increased its holdings in UnitedHealth Group by 14.1% during the 4th quarter. Diversified Trust Co now owns 49,745 shares of the healthcare conglomerate’s stock valued at $25,164,000 after purchasing an additional 6,158 shares during the period. Bangor Savings Bank increased its stake in shares of UnitedHealth Group by 7.5% in the 4th quarter. Bangor Savings Bank now owns 804 shares of the healthcare conglomerate’s stock worth $407,000 after acquiring an additional 56 shares in the last quarter. Canandaigua National Trust Co of Florida boosted its position in shares of UnitedHealth Group by 16.0% in the 4th quarter. Canandaigua National Trust Co of Florida now owns 875 shares of the healthcare conglomerate’s stock worth $443,000 after purchasing an additional 121 shares in the last quarter. Ables Iannone Moore & Associates Inc. increased its stake in UnitedHealth Group by 1.0% during the 4th quarter. Ables Iannone Moore & Associates Inc. now owns 3,848 shares of the healthcare conglomerate’s stock valued at $1,947,000 after purchasing an additional 37 shares in the last quarter. Finally, Fortem Financial Group LLC raised its holdings in UnitedHealth Group by 16.7% in the 4th quarter. Fortem Financial Group LLC now owns 818 shares of the healthcare conglomerate’s stock worth $414,000 after acquiring an additional 117 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $0.17 during trading on Tuesday, reaching $513.84. 2,697,353 shares of the stock traded hands, compared to its average volume of 3,533,434. The business has a fifty day simple moving average of $558.76 and a two-hundred day simple moving average of $561.51. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $472.88 billion, a price-to-earnings ratio of 33.47, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.56 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.